Skip to main content
HR 4082 109th Congress House

Biotechnology Future Investment Expansion Act of 2005

Official title: To permit biomedical research corporations to engage in certain financings and other transactions without incurring limitations on net operating loss carryforw… Show full official titleShow less

Official title: To permit biomedical research corporations to engage in certain financings and other transactions without incurring limitations on net operating loss carryforwards and certain built-in losses, and for other purposes.

Introduced: October 19, 2005 See on congress.gov
Taxation AccountingBiotechnologyCapital gains taxClinical trials
More subjectsShow fewer subjects
CommerceCorporate debtCorporate financeCorporate mergersCorporate reorganizationsCorporation taxesDrug industryFinance and Financial SectorHealthIncome taxInvestmentsLossesPharmaceutical researchScience, Technology, CommunicationsTax creditsTax exclusionTax incentives
Sign in to write a letter Sign in to watch
This bill died when the 109th Congress ended
It never became law before the 109th Congress (2005–2006) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Oct 19, 2005
Referred to the House Committee on Ways and Means.
Oct 19, 2005
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action October 19, 2005

Referred to the House Committee on Ways and Means.

 Plain-English summary Congressional Research Service

Biotechnology Future Investment Expansion Act of 2005 - Amends the Internal Revenue Code to permit certain biomedical research corporations to engage in investments and other transactions involving shifts in ownership without incurring limitations on net operating loss carryforwards and certain built-in losses.

 Related & companion bills 1
  • S 1893 Identical bill Biotechnology Future Investment Expansion Act of 2005
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 1
All 1 Democratic 1
D
Neal, Richard E.
Massachusetts · Oct 19, 2005
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 4082: Biotechnology Future Investment Expansion Act of 2005. 109th Congress. Open America. https://openamerica.io/bill/109-HR-4082/
MLA
"H.R. 4082: Biotechnology Future Investment Expansion Act of 2005." 109th Congress, 2026, Open America, https://openamerica.io/bill/109-HR-4082/.
Bluebook (legal)
H.R. 4082, 109th Cong. (2026), https://openamerica.io/bill/109-HR-4082/.
Markdown link
[H.R. 4082: Biotechnology Future Investment Expansion Act of 2005](https://openamerica.io/bill/109-HR-4082/)
Report a problem